BIT's 16th Annual Congress of International Drug Discovery Science & Technology-China 2018

The 16th Annual Congress of International Drug Discovery Science & Technology-China 2018  ( IDDST-China 2018) will be held on November 6-8, 2018 in the beautiful city of Jinan, China.

Given the major worldwide importance in drug research, new drug trials, and disease therapies, we should not only help ensure we’re apprised of current developments in the field but also reflect on new progress and look toward future challenges. IDDST-China 2018 enables presenters and delegates to enjoy the state of the art oral and poster presentations covering the recent advances from new drug discovery to clinical treatment .

IDDST-China 2018 will provide a unique and ideal opportunity for a broad spectrum of researchers, scientists and clinicians to meet, discuss, share, learn and connect in order to exchange ideas and experiences, and serve human health. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas to translate new discoveries a.

We hope your participation would contribute to your professional development and relationships. Wish you enjoy the conference.
Preliminary Program

Theme 0: Pre-Conference Warm-up
-Registration Day and Ice Breaking Party
Theme 2: Silkroad Partnership Post
-How B & R Can Accelerate Drug Discovery
Theme 4: Industrial Art Gallery
-From Drug R & D Pipelines to Market Development
Theme 6: Mind-Seeking Labs
-Your Career and Your Business
Theme 8: Roundtable for IDDST White Paper
-Opinions from Pharma Peers
Theme 1: Masters' Mind Honor Hall
-Vision from the World Leaders in Drug Discovery
Theme 3: Scientific Hub
-Frontier Science & Technology Research of the Future Drug Discovery
Theme 5: Young Pharmacists’ Nexus
-New Champions in Drug Discovery
Theme 7: Drug Discovery Bazaar
-Posters and Exhibits
Theme 9: Joyful Commune
-Sharing the Diversities for Common Interests
Past Renowned Speakers

Dr. Ei-ichi Negishi
H. C. Brown Distinguished Professor of Chemistry, Purdue University, USA
2010 Nobel Prize Laureate in Chemistry
Dr. Howard J. Federoff
Vice Chancellor of Health Affairs and Chief Executive Officer of Health System, University of California, Irvine, USA
Dr. Litao Zhang
Vice President, Leads Discovery and Optimization, Bristol-Myers Squibb, USA
Dr. Jan Hoflack
Chief Scientific and Operational Officer, Oncodesign SA, France
Dr. Akiyoshi Suganuma
Group Officer and President of BA-CFU, Medicine Development Center, Eisai Co., Ltd., Japan
Dr. David C. Bunton
Dr. Ming-Qiang Zhang
Vice President of Research & General Manager, Amgen BioPharmaceutical R&D (Shanghai) Co., Ltd., China
Dr. Patrice P. Denefle
VP & Head of the Roche Institute, Roche SAS, France
Dr. Chris H. Senanayake
Vice President, Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., USA
Dr. He (Henry) Sun
President and CEO, Tasly Pharmaceuticals, Inc., USA
Dr. Bruce Given
COO, Arrowhead Research Corporation, USA
Dr. Joseph P. Thomas
Chair of the Life Sciences Group and Co-chair of the Litigation Department, Ulmer & Berne LLP, USA
Dr. Mingde Xia
Senior Director, Johnson & Johnson Innovation Asia-Pacific, USA
Dr. Peter T. Meinke
Executive Director, External Discovery Chemistry, Merck Research Laboratories, China
Dr. Yong Qian
President & CEO,  BioMedicure LLC., USA and China
Dr. Han-Koo Lee
Honorary Chairman, Daehwa Pharmaceuticals Co. Ltd., South Korea
Dr. Hong Li
Chairman and Managing Director, Jiangsu Jiuxu Pharmaceutical Group, China
Dr. Seonggu Ro
Executive Vice President & CTO, CrystalGenomics, Inc., South Korea
说明: Mr. Sean Hall, 
CEO, Medlab Clinical Ltd., Australia
说明: Dr. Bruce Given, COO, 
Arrowhead Research Corporation, US
说明: Dr. Frank Roschangar, Director, 
Process Research & Global External Chemistry Management, Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., USA
说明: Dr. Volodymyr Kysil, 
Director of Chemistry, ChemDiv, Inc., USA
说明: Dr. Nils Hansen, 
CEO, Vipergen ApS, Denmark
说明: Dr. Raphael Nudelman, 
Associate Director, Head of Chemical & Computational Toxicology, Teva Pharmaceutical Industries Ltd., Israel
说明: Dr. Jianxun Xie, 
Head of Toxicology, Roche Innovation Center Shanghai, China
说明: Dr. Olivier Bezencon, 
Senior Group Leader, Actelion Pharmaceuticals Ltd., Switzerland
说明: Dr. Daniel Galbraith, 
Chief Scientist, Sartorius Stedim BioOutsource Ltd., UK
说明: Dr. Cyrus Khojasteh, 
Associate Director, Genentech, Inc., USA
说明: Mr. Avner Gal,
 President & CEO, Integrity Applications Ltd., Israel
说明: Dr. Mats Andersson, 
Founder and Chief Scientific Officer, Viscogel AB, Sweden
说明: Dr. Xujin Lu, 
Senior Principal Scientist, Bristol-Myers Squibb Company, USA
说明: Dr. Wen Zeng, 
President and CEO, Sichuan Primed Bio-tech Group Co., Ltd., China
说明: Mr. Mike Nelson, 
Partner, HGF Limited, UK
说明: Dr. Olaf Schoepke,
 Director of Strategic Development, Samarind Limited, UK
说明: Dr. Hak Jong Lee, 
Professor, Seoul National University, South Korea
说明: Dr. Xiang-Qun Xie, 
Associate Dean and Professor, School of Pharmacy, University of Pittsburgh, USA
说明: Dr. Pierre Vogel,
 Professor, Swiss Institute of Technology in Lausanne (EPFL), Switzerland
说明: Dr. Patrick Y. S. Lam, 
Adjunct Professor, Drexel University College of Medicine, USA
说明: Dr. Pavel Hobza, 
Professor,Institute of Organic Chemistry and Biochemistry AS CR, v.v.i., Czech Republic
说明: Dr. Dimiter S. Dimitrov, 
Senior Investigator, National Cancer Institute, NIH, USA
说明: Dr. Xinyuan Liu, 
Professor, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, China
说明: Dr. Hongtao Jin, 
Vice Director, New Drug Safety Evaluation Center (NDSEC), PUMC&CAMS; Beijing Union-Genius Pharma China
说明: Dr. Pierre Eftekhari, 
Founder and Director, Inoviem Scientific, Strasbourg University, France
说明: Dr. Shuji Kitagawa, 
President, Kobe Pharmaceutical University, Japan
说明: Dr. Randolph D Glickman, 
Professor, University of Texas Health Science Center, USA

Past Conference Report

BIT's 15th Annual Congress of International Drug Discovery Science and Technology-Japan 2017 (IDDST-Japan 2017) which was held in Hyatt Regency Osaka, Osaka, Japan on July 25-27, achieved a consummation. The theme of this conference is "Dedicated to Accelerating Drug Innovation". Over 400 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are 2010 Nobel Prize Laureate in Chemistry Dr. Ei-ichi Negishi, H. C. Brown Distinguished Professor of Chemistry in Purdue University; Dr. Howard J. Federoff, Vice Chancellor of Health Affairs and Chief Executive Officer of Health System in University of California, Irvine; Dr. Litao Zhang, Vice President of Bristol-Myers Squibb; Dr. Jan Hoflack, Chief Scientific and Operational Officer of Oncodesign SA; Dr. Akiyoshi Suganuma, Group Officer and President of BA-CFU in Medicine Development Center, Eisai Co., Ltd., Dr. David C. Bunton, CEO of REPROCELL Europe Ltd. …etc.

 View More...
Scenery of Jinan

Jinan, capital of Shandong Province, is located on a plain bordering on hilly country at the lower reaches of the Yellow River (Huanghe). Apart from it s beautiful scenery and mild climate, Jinan is known as the "City of Springs." The most scenic spots in Jinan are Daming Lake, Tai San Mountain, Five Dragon Pool and Thousand Buddha Hill.
News Updates
  • ◆ Speaking proposals are now being accepted,submit the abstract right now!
  • Online Registration is Open.
  • ◆Website of IDDST-China 2018 Released!
  • ◆ Welcome your participation as Session Chair/Session Speaker.
  • ◆ Seek for Co-Organizer.
  • ◆ Call for SAB Member.
Hosting Organizations

Information Research Center of International Talent, SAFEA

Ji'nan Branch of China Council for The Promotion of International Trade

Jinan Innovation Zone

Operating Organization
BIT Group Global Ltd.
Official Travel Agency
Media Partners

BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.